Zivo Bioscience, Inc. (ZIVO): Total Assets
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$1.64M
As of 2024-12-31
$559.5K
As of 2025-09-30
-43.2%
3-year compound annual growth
+34.8%
5-year compound annual growth
+32.1%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $1.64M | +195.7% | 2025-03-18, Balance as of period end |
| 2023-12-31 | $555.7K | -73.8% | 2025-03-18, Balance as of period end |
| 2022-12-31 | $2.12M | -76.4% | 2024-03-15, Balance as of period end |
| 2021-12-31 | $8.99M | n/m | 2023-03-14, Balance as of period end |
| 2020-12-31 | $220.2K | -40.4% | 2022-04-22, Balance as of period end |
| 2019-12-31 | $369.4K | -10.2% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $411.5K | +23.8% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $332.3K | -54.9% | 2019-02-12, Balance as of period end |
| 2016-12-31 | $737.3K | +914.4% | 2018-02-21, Balance as of period end |
| 2015-12-31 | $72.7K | -28.6% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $101.9K | -95.3% | 2016-03-29, Balance as of period end |
| 2013-12-31 | $2.17M | +829.2% | 2015-04-06, Balance as of period end |
| 2012-12-31 | $234.0K | -49.5% | 2014-03-31, Balance as of period end |
| 2011-12-31 | $463.5K | +36.4% | 2013-03-25, Balance as of period end |
| 2010-12-31 | $339.9K | n/a | 2012-03-30, Balance as of period end |